Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    LB 100

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    LIXTE Biotech to Attend DealFlow Conference Jan. 28-29
    LIXTE Biotech to Attend DealFlow Conference Jan. 28-29

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221630/0/en/LIXTE-Biotechnology-Attending-the-DealFlow-Discovery-Conference-January-28-29.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share
    LIXTE And Collaborators Expand Clear Cell Ovarian Cancer Trial
    LIXTE And Collaborators Expand Clear Cell Ovarian Cancer Trial

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3209841/0/en/LIXTE-and-its-Collaborators-Expand-Clear-Cell-Ovarian-Cancer-Trial.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share
    Focuses On Oncology Platform With Complementary Modalities
    Focuses On Oncology Platform With Complementary Modalities

    08 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-08/lixtes-strategy-comes-into-focus-building-an-oncology-platform-around-complementary-modalities

    PHARMIWEB
    08 Dec 2025
    Share Share
    LIXTE Levels Up From PP2A Innovation To Multi-Modal Oncology
    LIXTE Levels Up From PP2A Innovation To Multi-Modal Oncology

    03 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-03/lixte-levels-up-from-pp2a-innovation-to-multi-modal-oncology

    PHARMIWEB
    03 Dec 2025
    Share Share
    LIXTE Steps Into A Key Role In The Rise Of Treatment Amplifiers
    LIXTE Steps Into A Key Role In The Rise Of Treatment Amplifiers

    03 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-03/lixte-steps-into-a-key-role-in-the-rise-of-treatment-amplifiers

    PHARMIWEB
    03 Dec 2025
    Share Share
    Lixte Bio to Present at Spartan Capital Investor Conference 2025
    Lixte Bio to Present at Spartan Capital Investor Conference 2025

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176386/0/en/LIXTE-Biotechnology-Holdings-to-Present-at-the-Spartan-Capital-Investor-Conference-2025-November-3.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.